abstract |
CARBONYLAMINO PYROLOPYROZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING THEM. The present invention relates to carbonylamino pyrrolopyrazole compounds of formula I, compositions including such compounds and methods of use thereof are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as PAK4 inhibitors. |